Iron Deficiency: The Hidden Miscreant in Inflammatory Bowel Disease

E-ISSN： 1873-5592|15|11|1011-1019

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.11, 2014-10, pp. : 1011-1019

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory Bowel Disease in the Elderly

By > Pardi Darrell S.

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 617-624

Adis International

Access to resources Recommend Favorite

Macrophages in Inflammatory Bowel Disease

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 155-160

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics and Inflammatory Bowel Disease

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 3, 2008-09 ,pp. : 201-224

Bentham Science Publishers

Access to resources Recommend Favorite

Mesalazine for the treatment of inflammatory bowel disease

By Criscuoli Valeria

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite

Costs of Inflammatory Bowel Disease in Germany

By Stark Renee

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 797-814

Adis International

Access to resources Recommend Favorite